IP Library Granted Patent US 7,348,158
Granted Patent B2
US 7,348,158 · App. 10/502,959 · Granted Mar 25, 2008

Method of quantifying cholesterol in high density lipoprotein and reagent compositions

Assignee: Denka Seiken Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,348,158
App. No.
10/502,959
Granted
Mar 25, 2008
Kind
B2
Abstract

A method for specifically quantifying HDL cholesterol in which cholesterol in lipoproteins other than HDL is erased in the first step, and HDL cholesterol is specifically quantified in the second step, by which accurate values can be obtained even in measurements of abnormal samples such as disorder of lipid metabolism and lipoprotein abnormality, is disclosed. The method for quantifying cholesterol in high density lipoprotein according to the present invention comprises a first step of erasing cholesterol in lipoproteins other than high density lipoprotein by treating a test sample with cholesterol esterase and cholesterol oxidase in the absence of a surfactant which acts on high density lipoprotein and removing generated hydrogen peroxide; and a second step of adding a surfactant which specifically acts on high density lipoprotein to the product of said first step and quantifying hydrogen peroxide generated from cholesterol in high density lipoprotein by actions of cholesterol esterase and cholesterol oxidase. As the cholesterol oxidase used in the first step, one having a molecular weight of not more than 60 kilodaltons is used.

Claims (4)

1. A method for quantifying cholesterol in high density lipoprotein, which comprises: (a) erasing cholesterol in lipoproteins other than high density lipoprotein by treating a test sample with cholesterol esterase and low molecular weight cholesterol oxidase in the absence of a surfactant which acts on high density lipoprotein and removing generated hydrogen peroxide; (b) adding a surfactant which specifically acts on high density lipoprotein to the product of step (a), and (c) quantifying hydrogen peroxide generated from cholesterol in the high density lipoprotein of step (b) by actions of cholesterol esterase and low molecular weight cholesterol oxidase; wherein said low molecular weight cholesterol oxidase has a molecular weight of not more than 55.0 kilodaltons.

2. The method according to claim 1 , wherein said low molecular weight cholesterol oxidase has a molecular weight of 30 to 40 kilodaltons.

3. The method according to claim 1 or 2 , wherein said surfactant which specifically acts on the high density lipoprotein has an hydrophilicity-lipophilicity balance (HLB) value of 13 to 14.

4. The method according to claim 3 , wherein said surfactant which specifically acts on the high density lipoprotein is a polyalkylene oxide derivative.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBERS 10007286 AND 10415007 PREVIOUSLY RECORDED AT REEL: 054513 FRAME: 0142. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Dec 14, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 055437/0045 →
MERGER Recorded Nov 24, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 054513/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2004
From: MATSUI, HIROSHI; OHTA, MOTOKO
To: DENKA SEIKEN CO., LTD.
Reel/Frame 015864/0611 →
Priority Claims (1)
JP 2002-022587 · Jan 30, 2002 · national
Continuity (1)
Related Publication 20050095658A1 · May 5, 2005